The United States Permanent Representative to the United Nations; a Nobel Laureate; a pioneering cancer researcher and champion of women scientists; and a leading physician and medical journalist were among those honored at the 45th annual Commencement of the Icahn School of Medicine at Mount Sinai, held Friday, May 9, at Avery Fisher Hall.
The New York State Department of Health recently awarded The Mount Sinai Hospital’s Cardiac Catheterization (Cath) Laboratory the highest “two-star” safety rating for percutaneous coronary interventions (PCI) in overall and nonemergency cases. This marks the 16th consecutive year that the Cath Lab, or one of its physicians, has received this prestigious two-star rating for safety when performing PCI. The minimally invasive procedure, also known as angioplasty, is used to diagnose and treat patients with heart disease or blocked arteries.
Top prospects in this year’s National Football League draft stopped by Kravis Children’s Hospital at Mount Sinai on Thursday, May 8, the first day of the draft. They delighted pediatric patients with smiles, NFL goody bags, and visits to their rooms and to The Zone, a therapeutic and educational play area.
Specific cellular pathways, along which genetic mutations occur, appear to play a key role in the development of autism spectrum disorders (ASD), according to new research from Icahn School of Medicine at Mount Sinai.
The findings, published online in the April 24, 2014, issue of The American Journal of Human Genetics, provide scientists with a better understanding of the complex genetic architecture involved in ASD, which has its roots in early brain development.
The Icahn School of Medicine at Mount Sinai is launching a unique Master’s program specifically geared to give health care leaders new knowledge and skills as they confront the challenges of delivering patient care in an era of unprecedented reform. The Master’s Program in Health Care Delivery Leadership is offered through the Department of Health Evidence and Policy and is currently accepting applications for its inaugural cohort that begins this fall.
When colleagues nominated Joshua Lasseigne, BSN, RN, CHPN, a hospice and palliative care nurse at The Mount Sinai Hospital for a clinical excellence award, they summarized his exceptional skills in a nomination letter. “He truly helps patients and families through the darkest hours of their lives with a soft voice of hope and strong loving hugs,” they wrote. “He has a passion for nursing, a sense of optimism, and is an excellent role model and mentor.”
Mount Sinai leaders saluted the more than 1,200 volunteers who support The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai during a recent breakfast held to honor their commitment and dedication.
Following a performance by two volunteer flutists from the Music for Healing program, Peter W. May, Chairman, Boards of Trustees, Mount Sinai Health System, told guests: “There is a broad range of individuals who help Mount Sinai. While some have the capability to support us financially, many more give their valued time, spirit, and compassion to help patients, families, and staff. We salute your enthusiasm and accomplishments.”
Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.